Gene: HAS3
Official Full Name: hyaluronan synthase 3provided by HGNC
Gene Summary: The protein encoded by this gene is involved in the synthesis of the unbranched glycosaminoglycan hyaluronan, or hyaluronic acid, which is a major constituent of the extracellular matrix. This gene is a member of the NODC/HAS gene family. Compared to the proteins encoded by other members of this gene family, this protein appears to be more of a regulator of hyaluronan synthesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37413 | HAS3 Knockout cell line (HCT 116) | Human | HAS3 | 1:2~1:4 | Negative | Online Inquiry |
KO37414 | HAS3 Knockout cell line (HEK293) | Human | HAS3 | 1:3~1:6 | Negative | Online Inquiry |
KO37415 | HAS3 Knockout cell line (A549) | Human | HAS3 | 1:3~1:4 | Negative | Online Inquiry |
HAS3 Gene Knockout Cell Lines are engineered cellular models created to facilitate the in-depth study of hyaluronan synthesis and its downstream effects in various biological processes. These cell lines feature targeted deletions of the HAS3 gene, which encodes the enzyme hyaluronan synthase 3, integral to the biosynthesis of hyaluronan (HA). The disruption of this gene is pivotal for investigating how alterations in HA production influence cell behavior, including proliferation, migration, and immune responses.
The key functionality of HAS3 gene knockout cell lines lies in their ability to simulate hypo-hyaluronic states, enabling researchers to explore specific pathways involved in cancer metastasis, tissue repair, and inflammation. By using these cells, scientists can manipulate and examine the impact of diminished HA levels on cellular interactions and microenvironmental dynamics. Additionally, the knockout models provide a platform for testing therapeutic approaches aimed at regulating HA synthesis, with potential applications in treating conditions such as cancer, arthritis, and fibrosis.
Compared to traditional cell lines or random gene editing methods, HAS3 gene knockout lines offer a more precise and reproducible approach to studying HA-related phenomena. Their specific targeting of the HAS3 gene reduces variability, providing clearer insights into the pathways of interest. This level of specificity not only enhances experimental design but also improves the reliability of data analysis.
For researchers and clinicians, the value of HAS3 gene knockout cell lines is substantial. They represent a critical tool for elucidating the role of HA in health and disease, thus advancing knowledge and fostering the development of novel therapeutic strategies. With a focus on innovation, our company is dedicated to providing high-quality biological products that contribute to cutting-edge research and clinical advancements. Our expertise in cellular engineering ensures that each product supports the rigorous demands of the scientific community, facilitating breakthroughs in understanding complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.